Triamcinolone vs Tetracosactide for Chronic Rotator Cuff Tendinitis .
The comparison of the efficacy of intramuscular tetracosactide and subacromial triamcinolone injection in rotator cuff tendinitis: a randomized trial.
Rheumatol Adv Pract . 2024 Dec 20;9(1):rkae150. dEighty-six patients with chronic RCT were randomized to receive subacromial triamcinolone acetonide 40 mg (n=43) or IM tetracosactide 1 mg (n=43). The primary outcome was change in pain (VAS) at 4 weeks; secondary outcomes included Constant–Murley (CM) functional score and categorical VAS severity. Outcomes were assessed at baseline and 4 weeks. Overall, the results showed larger pain reduction with triamcinolone than tetracosactide, and a greater CM improvement with triamcinolone. In short, both treatments helped, but subacromial triamcinolone was more effective for 4-week pain relief and functional gain.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
